Skip to main content

Advertisement

Table 1 miRNAs differentially expressed between CRC and normal colorectal tissue.

From: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer

miRNA Normala CRCa p-value fold changeb Locationc CRC Fragile sited
hsa-miR-20a 9.2 10.3 2.0E-03 2.1 13q31.3 gain
hsa-miR-18a 7.6 8.6 2.9E-03 2.0 13q31.3 gain
hsa-miR-19a 7.7 8.7 2.3E-03 1.9 13q31.3 gain
hsa-miR-17-5p 10.5 11.4 1.5E-03 1.9 13q31.3 gain
hsa-miR-19b 11.0 11.8 3.4E-03 1.8 13q31.3 gain
hsa-miR-203 8.4 9.7 2.2E-02 2.6 14q32.33 loss
hsa-miR-21 13.0 14.5 6.0E-06 2.9 17q23.2 gain
hsa-miR-34a 9.5 10.3 1.5E-02 1.7 1p36.22 loss
hsa-miR-181b 8.5 9.2 2.2E-04 1.7 1q31.1 or 9q33.3 gain (1q)
hsa-miR-29b 9.7 10.5 4.9E-03 1.8 1q32.2 or 7q32.3 gain
hsa-miR-130b 7.1 7.8 1.2E-03 1.7 22q11.21 loss
hsa-miR-95 6.1 6.8 1.1E-02 1.6 4p16.1 loss
hsa-miR-106b 9.5 10.3 1.0E-04 1.7 7q22.1 gain
hsa-miR-93 9.9 10.5 3.4E-03 1.6 7q22.1 gain
hsa-miR-25 9.0 9.6 1.4E-02 1.6 7q22.1 gain
hsa-miR-182 7.2 8.7 2.8E-03 2.8 7q32.2 gain
hsa-miR-96 6.7 7.7 8.4E-03 2.0 7q32.2 gain
hsa-miR-183 5.9 6.8 2.3E-03 1.8 7q32.2 gain
hsa-miR-29a 12.1 12.9 3.6E-04 1.7 7q32.3 gain
hsa-miR-31 6.4 8.7 2.6E-03 5.0 9p21.3  
hsa-miR-106a 10.7 11.7 5.1E-04 2.0 Xq26.2  
hsa-miR-224 6.9 8.4 1.1E-03 2.8 Xq28  
hsa-miR-30a-5p 11.6 11.0 1.6E-05 0.7 6q13 loss
hsa-miR-30a-3p 7.1 6.3 7.3E-04 0.5 6q13 loss
hsa-miR-378* 7.6 6.5 1.3E-05 0.4 5q32 loss
hsa-miR-422b 10.9 9.6 8.3E-05 0.4 5q32 loss
hsa-miR-143 14.1 12.6 1.0E-02 0.4 5q32 loss
hsa-miR-145 15.0 13.2 1.2E-03 0.3 5q32 loss
hsa-miR-10b 11.0 10.1 2.1E-02 0.5 2q31.1  
hsa-miR-30c 10.9 10.3 4.0E-04 0.7 1p34.2 or 6q13 loss
hsa-miR-125a 11.2 10.2 6.4E-03 0.5 19q13.41 gain
hsa-miR-1 9.0 7.0 1.6E-03 0.2 18q12.3 or 20q13.33 loss (18q) or gain (20q)
hsa-miR-133a 10.0 7.6 6.5E-04 0.2 18q12.3 or 20q13.33 loss (18q) or gain (20q)
hsa-miR-497 9.3 8.1 9.8E-04 0.4 17p13.1 loss
hsa-miR-195 11.1 9.5 4.2E-05 0.3 17p13.1 loss
hsa-miR-422a 10.0 8.8 7.3E-05 0.4 15q22.31 loss
hsa-miR-139 7.6 6.2 1.1E-05 0.4 11q13.4 loss
  1. a. normalized median signal intensity (log2)
  2. b. cancer:normal
  3. c. Chromosomal location of some miRNAs equivocal since MirVana Bioarray does not discriminate between pre-miRNA precursors.
  4. d. Frequent chromosomal gains or lossesd in CRC as summarized from [31].